Search Results - "Main, Michael L"

Efficacy of Direct Acting Oral Anticoagulants in Treatment of Left Ventricular Thrombus by Fleddermann, Adam M., Hayes, Charles H., Magalski, Anthony, Main, Michael L.

“…Direct acting oral anticoagulants (DOACs) are increasingly used as off-label alternatives to vitamin K antagonists for the treatment of left ventricular (LV)…”
Get full text

Clinical Applications of Ultrasonic Enhancing Agents in Echocardiography: 2018 American Society of Echocardiography Guidelines Update by Porter, Thomas R., Mulvagh, Sharon L., Abdelmoneim, Sahar S., Becher, Harald, Belcik, J. Todd, Bierig, Michelle, Choy, Jonathan, Gaibazzi, Nicola, Gillam, Linda D., Janardhanan, Rajesh, Kutty, Shelby, Leong-Poi, Howard, Lindner, Jonathan R., Main, Michael L., Mathias, Wilson, Park, Margaret M., Senior, Roxy, Villanueva, Flordeliza

Get full text

Assessment of Device Related Thrombus and Associated Clinical Outcomes with the WATCHMAN Left Atrial Appendage Closure Device for Embolic Protection in Patients with Atrial Fibrillation (From the PROTECT-AF Trial) by Main, Michael L., MD, Fan, Dali, MD, PhD, Reddy, Vivek Y., MD, Holmes, David R., MD, Gordon, Nicole T., BSEE, Coggins, Tina R., RDCS, House, John A., MS, Liao, Lawrence, MD, Rabineau, Dawn, RDCS, Latus, George G., BSBME, Huber, Kenneth C., MD, Sievert, Horst, MD, Wright, Richard F., MD, Doshi, Shephal K., MD, Douglas, Pamela S., MD

“…Abstract Left atrial appendage (LAA) closure with the WATCHMAN device is an alternative to anticoagulation for stroke prevention in selected patients with…”
Get full text

Efficacy and Safety of Left Atrial Appendage Closure With WATCHMAN in Japanese Nonvalvular Atrial Fibrillation Patients　― Final 2-Year Follow-up Outcome Data From the SALUTE Trial by Aonuma, Kazutaka, Yamasaki, Hiro, Nakamura, Masato, Matsumoto, Takashi, Takayama, Morimasa, Ando, Kenji, Hirao, Kenzo, Goya, Masahiko, Morino, Yoshihiro, Hayashida, Kentaro, Kusano, Kengo, Gomi, Yutaka, Main, Michael L., Uchida, Takahiro, Saito, Shigeru

“…Background:The SALUTE trial was a prospective, multicenter, single-arm trial to confirm the safety and efficacy of the WATCHMAN left atrial appendage closure…”
Get full text

Percutaneous WATCHMAN Left Atrial Appendage Closure for Japanese Patients With Nonvalvular Atrial Fibrillation at Increased Risk of Thromboembolism　― First Results From the SALUTE Trial by Aonuma, Kazutaka, Yamasaki, Hiro, Nakamura, Masato, Ootomo, Tatsushi, Takayama, Morimasa, Ando, Kenji, Hirao, Kenzo, Morino, Yoshihiro, Hayashida, Kentaro, Kusano, Kengo, Main, Michael L., Saito, Shigeru

“…Background: The PROTECT AF and PREVAIL trials demonstrated that the WATCHMAN left atrial appendage (LAA) closure device is a reasonable alternative to warfarin…”
Get full text

Acute Mortality in Hospitalized Patients Undergoing Echocardiography With and Without an Ultrasound Contrast Agent (Multicenter Registry Results in 4,300,966 Consecutive Patients) by Main, Michael L., MD, Ryan, Amy C., MS, Davis, Teresa E., BS, Albano, Maureen P., RN, Kusnetzky, Lisa L., BA, Hibberd, Mark, MD

“…We sought to define acute mortality in a large multicenter cohort of hospitalized patients undergoing clinically indicated echocardiography with and without…”
Get full text

Thinking Outside the “Box”—The Ultrasound Contrast Controversy by Main, Michael L., MD, FACC, Goldman, Jonathan H., MD, FACC, Grayburn, Paul A., MD, FACC

“…Thinking Outside the “Box”—The Ultrasound Contrast Controversy Michael L. Main, Jonathan H. Goldman, Paul A. Grayburn On October 10, 2007, the U.S. Food and…”
Get full text

Relation of Race to Electrocardiographic Patterns in Elite American Football Players by Magalski, Anthony, MD, FACC, Maron, Barry J., MD, FACC, Main, Michael L., MD, FACC, McCoy, Marcia, RN, MSN, Florez, Angela, BA, Reid, Kimberly J., MS, Epps, Harold W., MED, ATC, LAT, Bates, John, MD, FACC, Browne, Jon E., MD

“…Relation of Race to Electrocardiographic Patterns in Elite American Football Players Anthony Magalski, Barry J. Maron, Michael L. Main, Marcia McCoy, Angela…”
Get full text

Acute Mortality in Critically Ill Patients Undergoing Echocardiography With or Without an Ultrasound Contrast Agent by Main, Michael L., MD, Hibberd, Mark G., MD, PhD, Ryan, Amy, MS, Lowe, Timothy J., PhD, Miller, Paula, BS, Bhat, Gajanan, PhD

“…Objectives The objective of this observational study was to compare 48-h all-cause mortality (as well as hospital stay mortality) among critically ill patients…”
Get full text

Cardiovascular Screening with Electrocardiography and Echocardiography in Collegiate Athletes by Magalski, Anthony, MD, McCoy, Marcia, RN, MSN, Zabel, Michael, MD, Magee, Lawrence M., MD, Goeke, Joseph, MD, Main, Michael L., MD, Bunten, Linda, RN, BSN, Reid, Kimberly J., MS, Ramza, Brian M., MD, PhD

“…Abstract Background Current guidelines for preparticipation screening of competitive athletes in the US include a comprehensive history and physical…”
Get full text

Safety of Ultrasound Contrast Agents in Patients With Known or Suspected Cardiac Shunts by Parker, Jeremy M., MD, Weller, Mark W., JD, Feinstein, Linda Maiman, JD, Adams, Robin J., BS, Main, Michael L., MD, Grayburn, Paul A., MD, Cosgrove, David O., MD, Goldberg, Barry A., MD, Darge, Kassa, MD, PhD, Nihoyannopoulos, Petros, MD, Wilson, Stephanie, MD, Monaghan, Mark, PhD, Piscaglia, Fabio, MD, Fowlkes, Brian, PhD, Mathias, Wilson, MD, Moriyasu, Fuminari, MD, PhD, Chammas, Maria Christina, MD, PhD, Greenbaum, Lennard, MD, Feinstein, Steven B., MD

“…Contrast-enhanced ultrasound imaging is a radiation-free diagnostic tool that uses biocompatible ultrasound contrast agents (UCAs) to improve image clarity…”
Get full text

Evaluation of Appropriate Use of Transthoracic Echocardiography in 1,820 Consecutive Patients Using the 2011 Revised Appropriate Use Criteria for Echocardiography by Patil, Harshal R., MD, Coggins, Tina R., RDCS, Kusnetzky, Lisa L., BA, Main, Michael L., MD

“…Revised Appropriate Use Criteria (AUC) for Echocardiography were published in 2011 and classify potential procedure indications as appropriate (score of 7 to…”
Get full text

CEUS cardiac exam protocols International Contrast Ultrasound Society (ICUS) recommendations by Porter, Thomas R, Feinstein, Steven B, Senior, Roxy, Mulvagh, Sharon L, Nihoyannopoulos, Petros, Strom, Jordan B, Mathias, Wilson, Gorman, Beverly, Rabischoffsky, Arnaldo, Main, Michael L, Appis, Andrew

“…Abstract The present CEUS Cardiac Exam Protocols represent the first effort to promulgate a standard set of protocols for optimal administration of ultrasound…”
Get full text

Impact of Transesophageal Echocardiography on Management in Patients With Suspected Cardioembolic Stroke by Khariton, Yevgeniy, MD, House, John A., MS, Comer, Lynn, RN, Coggins, Tina R., RDCS, Magalski, Anthony, MD, Skolnick, David G., MD, Good, Thomas H., MD, Main, Michael L., MD

“…Transesophageal echocardiography (TEE) is frequently performed in patients with acute ischemic cerebrovascular events to exclude a cardioembolic source. We…”
Get full text

Transesophageal echocardiographic diagnosis of a WATCHMAN left atrial appendage closure device thrombus 10 years following implantation by Shamim, Shariq, Magalski, Anthony, Chhatriwalla, Adnan K., Allen, Keith B., Huber, Kenneth C., Main, Michael L.

“…Left atrial appendage closure with the WATCHMAN device is an alternative to chronic oral anticoagulation for thromboembolic prophylaxis in atrial fibrillation…”
Get full text

CaRES (Contrast Echocardiography Registry for Safety Surveillance): A Prospective Multicenter Study to Evaluate the Safety of the Ultrasound Contrast Agent Definity in Clinical Practice by Weiss, Robert J., MD, Ahmad, Masood, MD, Villanueva, Flordeliza, MD, Schmitz, Stephen, MD, MPH, Bhat, Gajanan, PhD, Hibberd, Mark G., MD, PhD, Main, Michael L., MD

“…Background Definity (perflutren lipid microsphere) is an ultrasound contrast agent approved for use in patients with suboptimal echocardiograms to opacify the…”
Get full text

Sudden Cardiac Arrest in Hypertrophic Cardiomyopathy in the Absence of Conventional Criteria for High Risk Status by Maron, Barry J., MD, Maron, Martin S., MD, Lesser, John R., MD, Hauser, Robert G., MD, Haas, Tammy S., RN, Harrigan, Caitlin J., BA, Appelbaum, Evan, MD, Main, Michael L., MD, Roberts, William C., MD

“…Two patients with hypertrophic cardiomyopathy are reported from the recent experience of the Hypertrophic Cardiomyopathy Center of the Minneapolis Heart…”
Get full text

Appropriate Use of Transthoracic Echocardiography by Rao, Gowtham, MD, MPH, Sajnani, Nitin, MD, Kusnetzky, Lisa L., BA, Main, Michael L., MD

“…The appropriateness criteria for echocardiography were published in 2007 and classified potential procedural indications as appropriate, uncertain, or…”
Get full text

Effect of Renal Transplantation for Chronic Renal Disease on Left Ventricular Mass by Vaidya, Omkar U., MD, House, John A., MS, Coggins, Tina R., RDCS, Patil, Harshal, MD, Vaidya, Anwita, BDS, Awad, Ahmed, DO, Main, Michael L., MD

“…Chronic kidney disease is associated with an increased left ventricular (LV) mass. Few data are available regarding the effect of renal transplantation on LV…”
Get full text

Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes by Dukkipati, Srinivas R, Kar, Saibal, Holmes, David R, Doshi, Shephal K, Swarup, Vijendra, Gibson, Douglas N, Maini, Brijeshwar, Gordon, Nicole T, Main, Michael L, Reddy, Vivek Y

“…BACKGROUND:In patients with atrial fibrillation, left atrial appendage closure with the Watchman device prevents thromboembolism from the left atrial…”
Get full text